On the occasion of the BIO-Europe Spring 2017 event in Barcelona, the newspaper “La Vanguardia” has published an article about the campaign to host the new headquarters of the London-based European Medicines Agency (EMA) after Brexit.
The article also includes a reference to the participation of IRB Barcelona’s Innovation Department in this three-day partnering conference for the biotechnology industry.
The “Innovadores” supplement of El Mundo publishes a report on the "Valley of Death" in biolotechnology. This term refers to the phases that between a scientific discovery and it reaching the market.
The article includes comments by experts Delia Zabra, from the Innovation Department at IRB Barcelona, and ICREA researcher Roger Gomis, founder of the spin-off company Inbiomotion.
Virgil Simons from Radio Kanal Barcelona has interviewed ICREA researcher Roger Gomis about breast cancer. Gomis is one of the co-authors of an article recently published in Lancet Oncology in which they identified a group of patients with early breast cancer who could benefit from a preventive treatment of metastasis.
Link to Radio Kanal Barcelona
ICREA researcher Roger Gomis, head of the Growth Control and Cancer Metastasis Lab, has recently been awarded a 2016 "Knowledge Industry Grant" (Producte), by the Catalan Government’s Agency for Management of University and Research Grants, for the further development of a therapy for the treatment of breast cancer. His 18-month project, "Lipid targeting in breast cancer", aims to obtain a monoclonal antibody, based on a well-defined molecular target, that is suitable for patient treatment and to complete its pre-clinical development phase.
